About: Rapidly progressive interstitial lung disease due to anti-MDA5 antibodies without skin involvement: a case report and literature review

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Rapidly progressive interstitial lung disease due to anti-MDA5 antibodies without skin involvement: a case report and literature review Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Rapidly progressive interstitial lung disease due to anti-MDA5 antibodies without skin involvement: a case report and literature review
Creator	Ana, · Colom, Bartomeu González-Moreno, Juan Losada-Lopez, Ines Oliver, Cristina Raya-Cruz, Manuel Cacheda, Paula
Source	PMC
abstract	Anti-MDA5 antibodies have been strongly associated with rapidly progressive interstitial lung disease (RP-ILD) in dermatomyositis (DM) patients, especially in the clinically amyopathic subset (CADM). We present a case of anti-MDA5 antibody-associated RP-ILD in a patient with arthritis but with no other clinical signs suggestive of DM or CADM successfully treated with a combination of cyclophosphamide, cyclosporine and corticoids. A review of the literature was also done. Despite its rarity, anti-MDA5 antibody-associated ILD should be suspected in cases of RP-ILD even without other signs of DM or CADM as prompt and aggressive treatment could improve prognosis.
has issue date	2018-02-07(xsd:dateTime)
bibo:doi	10.1007/s00296-018-3991-7
bibo:pmid	29417209
has license	no-cc
sha1sum (hex)	f022b2c00751d8c33afb91e4d29188aaf4268815
schema:url	https://doi.org/10.1007/s00296-018-3991-7
resource representing a document's title	Rapidly progressive interstitial lung disease due to anti-MDA5 antibodies without skin involvement: a case report and literature review
has PubMed Central identifier	PMC7101732
has PubMed identifier	29417209
schema:publication	Rheumatol Int
resource representing a document's body	covid:f022b2c00751d8c33afb91e4d29188aaf4268815#body_text
is schema:about of	named entity 'skin' named entity 'literature review' named entity 'CYCLOSPORINE' named entity 'BUT' named entity 'REVIEW OF THE LITERATURE' named entity 'suspected' named entity 'cyclosporine' named entity 'anti-Jo1' named entity 'ANCA' named entity 'aggressive' named entity 'clinical signs' named entity 'CADM' named entity 'dermatomyositis' named entity 'prognosis' named entity 'cyclophosphamide' named entity 'CADM' named entity 'Cyclophosphamide' named entity 'cyclophosphamide' named entity 'MDA5' named entity 'lung disease' named entity 'antibodies' named entity 'CRP' named entity 'melanoma' named entity 'crackles' named entity 'PaO2/FiO2' named entity 'lung' named entity 'prednisone' named entity 'MDA5' named entity 'antibody' named entity 'CADM' named entity 'Spanish language' named entity 'cardiac involvement' named entity 'physical examination' named entity 'muscle strength' named entity 'metacarpophalangeal joints' named entity 'acute respiratory distress syndrome' named entity 'Creatine kinase' named entity 'inflammatory markers' named entity 'extrapulmonary' named entity 'antibodies' named entity 'MDA5' named entity 'HIV' named entity 'antibody' named entity 'gene' named entity 'X-ray' named entity '1, 2' named entity 'dermatomyositis' named entity 'antibody' named entity 'MDA5' named entity 'MDA5' named entity 'histological' named entity 'diffuse alveolar damage' named entity 'MDA5' named entity 'prognosis' named entity 'lung' named entity 'antibody' named entity 'antibodies' named entity 'lung disease' named entity 'germs' named entity 'clinical diagnosis' named entity 'velcro' named entity 'thoracic' named entity 'lactate dehydrogenase' named entity 'clinical characteristics' named entity 'antinuclear antibodies' named entity 'antibodies' named entity 'aPL' named entity 'MDA5' named entity 'bronchoscopy' named entity '1, 2' named entity 'myositis' named entity 'interstitial lung disease' named entity 'first-line therapy' named entity 'PubMed' named entity 'myositis'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software